Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis serogroup B proteins comprise a diverse group of surface-exposed and secreted proteins critical for bacterial survival, virulence, and immune evasion. They include outer membrane proteins such as factor H-binding protein (FHbp), neisserial heparin binding antigen (NHBA), Neisseria adhesin A (NadA), and various porins. Several of these proteins serve as key antigens in serogroup B meningococcal vaccines. Other proteins are involved in adhesion, iron uptake, and complement evasion. The group is not a single molecular target, but an immunologically and clinically important collection of bacterial proteins. The term is non-specific and incorporates multiple targets with variable molecular structure and function.
Vaccines elicit antibody responses to these proteins, blocking bacterial attachment, neutralizing toxins, or promoting complement-mediated lysis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis serogroup B protein.